7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Clinical trial NCT05480761 · TERMINATED

Trial details

NCT number: NCT05480761
Sponsor: QOL Medical, LLC
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Sucrase-Isomaltase Deficiency CSID Sucrase Isomaltase Deficiency

Start date: 2022-08-01
Primary completion: 2024-09-18
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.